References
- Schroit, A. J. and Zwaal, R. F. A., 1991, Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim. Biophys. Acta, 1071, 313 –329.
- Devaux, P. F., 1992, Protein involvement in transmembrane lipid asymmetry. Annu. Rev. Biophys. Biomol. Struct., 21, 417 – 439.
- Connor, J., Pak, C. H., Zwaal, R. F. A. and Schroit, A. J., 1992, Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. J. Biol. Chem., 267, 19412–19417.
- Bitbol, M. and Devaux, P. F., 1988, Measurement of outward translocation of phospholipids across human erythrocyte mem- brane. Proc. Natl Acad. Sci., USA, 85, 6783 -6787.
- Morrot, G., Zachowski, A. and Devaux, P. F., 1990, Partial purification and characterization of the human erythrocyte Mg2+-ATPase. A candidate aminophospholipid translocase. FEBS Lett., 266, 29 –32.
- Daleke, D. L. and Lyles, J. V., 2000, Identification and purification of aminophospholipid flippases. Biochim. Biophys. Acta, 1486, 108 –127.
- Dekkers, D. W. C., Comfurius, P., Schroit, A. J., Bevers, E. M. and Zwaal, R. F. A., 1998, Transbilayer movement of nbd- labeled phospholipids in red blood cell membranes: outward- directed transport by the multidrug resistance protein 1 (mrp1). Biochemistry, 37, 14833–14837.
- Williamson, P., Bevers, E. M., Smeets, E. F., Comfurius, P., Schlegel, R. A. and Zwaal, R. F., 1995, Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry, 34, 10448–10455.
- Rosing, J., van Rijn, J. L. M. L., Bevers, E. M., van Dieijen, G., Comfurius, P. and Zwaal, R. F. A., 1985, The role of activated human platelets in prothrombin and factor x activation. Blood, 65, 319 –332.
- Schroit, A. J., Madsen, J. W. and Tanaka, Y., 1985, In vivo recognition and clearance of red blood cells containing phos- phatidylserine in their plasma membranes. J. Biol. Chem., 260, 5131 -5138.
- Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. and Henson, P. M., 1992, Exposure of phospha- tidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol., 148, 2207 -2216.
- Zhou, Q., Zhao, J., Wiedmer, T. and Sims, P. J., 2002, Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood, 99, 4030 -4038.
- Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J. and Shattil, S. J., 1989, Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem., 264, 17049–17057.
- Chang, C.-P., Zhao, J., Wiedmer, T. and Sims, P. J., 1993, Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylser- ine. J. Biol. Chem., 268, 7171 -7178.
- Fox, J. E. B., Austin, C. D., Reynolds, C. C. and Steffen, P. K., 1991, Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem., 266, 13289–13295.
- DacharyPrigent, J., Pasquet, J. M., Freyssinet, J. M. and Nurden, A. T., 1995, Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: A study using Ca2+-ATPase inhibitors. Biochemistry, 34, 11625–11634.
- Smeets, E. F., Comfurius, P., Bevers, E. M. and Zwaal, R. F., 1994, Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim. Biophys. Acta, 1195, 281 –286.
- Williamson, P., Kulick, A., Zachowski, A., Schlegel, R. A. and Devaux, P. F., 1992, Ca2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry, 31, 6355–6360.
- Sheetz, M. P. and Singer, S. J., 1974, Biological membranes as bilayer couples. A molecular mechanism of drug -erythrocyte interactions. Proc. Natl Acad. Sci., USA, 71, 4457 -4461.
- Sheetz, M. P., Painter, R. G. and Singer, S. J., 1976, Biological membranes as bilayer couples. III. Compensatory shape changes induced in membranes. J. Cell Biol., 70, 193 –203.
- Devaux, P. F., 2000, Is lipid translocation involved during endo- and exocytosis? Biochimie, 82, 497 –509.
- Hagerstrand, H., Holmstrom, T. H., BobrowskaHagerstrand, M., Eriksson, J. E. and Isomaa, B., 1998, Amphiphile-induced phosphatidylserine exposure in human erythrocytes. Mol. Memb. Biol., 15, 89 –95.
- Hagerstrand, H., Bobacka, J., Bobrowska-Hagerstrand, M., Kralj-Iglic, V., Fosnaric, M. and Iglic, A., 2001, Oxyethylene chain -cation complexation: Nonionic polyoxyethylene deter- gents attain a positive charge and demonstrate electrostatic head group interactions. Cell. Mol. Biol. Lett., 6, 161 –165.
- Hagerstrand, H., Bobrowski-Hagerstrand, M. and Isomaa, B., 1996, Do shape transformations in erythrocytes reflect the flip rate of amphiphilic compounds? Cell. Mol. Biol. Lett., 1, 3 –14. [25] Daleke, D. L. and Huestis, W. H., 1989, Erythrocyte morphology reflects the transbilayer distribution of incorporated phospholi- pids. J. Cell Biol., 108, 1375–1385.
- Pantaler, E., Kamp, D. and Haest, C. W., 2000, Acceleration of phospholipid flip-flop in the erythrocyte membrane by deter- gents differing in polar head group and alkyl chain length. Biochim. Biophys. Acta, 1509, 397 –408.
- Comfurius, P., Senden, J. M., Tilly, R. H., Schroit, A. J., Bevers, E. M. and Zwaal, R. F., 1990, Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim. Biophys. Acta, 1026, 153 –160.
- Manno, S., Takakuwa, Y. and Mohandas, N., 2002, Identifica- tion of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine -skeletal protein interactions modulate membrane stability. Proc. Natl Acad. Sci., USA, 99, 1943 –1948.
- Huang, C. L., Yeh, J. Z. and Muni, I. A., 1970, Comparative distribution, excretion, and metabolism of 14C-labeled quatern- ary ammonium compounds of promazine, chlorpromazine, and triflupromazine. J. Pharm. Sci., 59, 1114 -1118.